Correlation Between Sparx Technology and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sparx Technology and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sparx Technology and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sparx Technology and Pfizer Inc CDR, you can compare the effects of market volatilities on Sparx Technology and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sparx Technology with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sparx Technology and Pfizer.

Diversification Opportunities for Sparx Technology and Pfizer

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sparx and Pfizer is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Sparx Technology and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Sparx Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sparx Technology are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Sparx Technology i.e., Sparx Technology and Pfizer go up and down completely randomly.

Pair Corralation between Sparx Technology and Pfizer

Assuming the 90 days trading horizon Sparx Technology is expected to generate 31.54 times more return on investment than Pfizer. However, Sparx Technology is 31.54 times more volatile than Pfizer Inc CDR. It trades about 0.05 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.08 per unit of risk. If you would invest  3.50  in Sparx Technology on September 5, 2024 and sell it today you would earn a total of  2,662  from holding Sparx Technology or generate 76071.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Sparx Technology  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Sparx Technology 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Sparx Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Sparx Technology showed solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Sparx Technology and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sparx Technology and Pfizer

The main advantage of trading using opposite Sparx Technology and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sparx Technology position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Sparx Technology and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years